# Niagen Bioscience, Inc. (NAGE) insider trading, Q3 2026

Canonical: https://sec-api.dev/insider-trading/nage

> 3 non-derivative transactions: 0 purchases, 0 sales. CIK 1386570.

| Date | Insider | Relationship | Code | Shares | Price | Owned after | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 2026-06-30 | Fried Robert N | Director, Officer | A | 1106.0 | 2.71 | 1060087.0 | https://www.sec.gov/Archives/edgar/data/1386570/000141795226000002/0001417952-26-000002-index.htm |
| 2026-06-30 | Pamir Ozan | Officer | A | 4255.0 | 2.71 | 11627.16 | https://www.sec.gov/Archives/edgar/data/1386570/000183468126000001/0001834681-26-000001-index.htm |
| 2026-06-30 | Lopez Carlos Luis | Officer | A | 2314.0 | 2.71 | 4565.0 | https://www.sec.gov/Archives/edgar/data/1386570/000204250926000001/0002042509-26-000001-index.htm |

Source: https://www.sec.gov/data-research/sec-markets-data/insider-transactions-data-sets

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.
API: https://sec-api.dev/docs · ChatGPT app: https://chatgpt.com/plugins/plugin_asdk_app_6ae0ef2436ac8191941dae8a4d732669 · Free key: https://sec-api.dev/sign-up